QR-Code

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma

Studies on immune checkpoint inhibitors targeting B7-CD28 family pathways in esophageal squamous cell carcinoma (ESCC) have shown promising results. However, a comprehensive understanding of B7-CD28 family members in ESCC is still limited. This study aimed to construct a novel B7-CD28 family-based p...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Chaoqi Zhang, Feng Wang, Nan Sun, Zhen Zhang, Guochao Zhang, Zhihui Zhang, Yuejun Luo, Yun Che, Hong Cheng, Jiagen Li, Jie He
Format: Artigo
Sprache:Inglês
Veröffentlicht: KeAi Communications Co., Ltd. 2022-03-01
Schriftenreihe:Genes and Diseases
Schlagworte:
Esophageal cancer
HHLA2
ICOSLG
Immune checkpoint
Immunotherapy
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2352304220301082
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge